Encompass HealthvsJohnson & Johnson

EHC and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

EHC

Encompass Health Corporation

$134.93

Value $13.4B

-2.14%
EHC's page

Encompass Health (EHC) has a market value of $13.4B and Johnson & Johnson (JNJ) $657B. Over the last year, with dividends, EHC moved +21.4% and JNJ +39.7%. The P/E is 20.9 for EHC and 40.8 for JNJ. Dividend yield: EHC 0.58%, JNJ 1.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    EHC$13.4B

    JNJ$657B

    JNJ is 49 times EHC

  • Revenue, 12 months

    EHC$6.3B

    JNJ$99.3B

    JNJ is 16 times EHC

  • Net income, 12 months

    EHC$644M

    JNJ$16.1B

    JNJ is 25 times EHC

  • Operating margin

    EHC–

    JNJ–

  • ROIC

    EHC16.7%

    JNJ12.4%

    4.3 points apart

  • P/E

    EHC20.9

    JNJ40.8

    JNJ is 2.0 times EHC

  • Dividend yield

    EHC0.6%

    JNJ1.9%

    1.3 points apart

  • 5-year return

    EHC+180.0%

    JNJ+92.0%

    88.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

EHC+179.9%

JNJ+92.0%

10020030020222023202420252026
Returns by period
PeriodEHCWith dividendsJNJWith dividends
1 year since November 17, 2025+21.4%Price +20.5%+39.7%Price +36.6%
3 years since November 17, 2023+114.3%+28.9% a yearPrice +109.7%+98.2%+25.6% a yearPrice +82.1%
5 years since November 17, 2021+180.0%+22.9% a yearPrice +166.7%+92.0%+13.9% a yearPrice +67.0%
10 years since November 18, 2016+374.2%+16.8% a yearPrice +314.0%+208.0%+11.9% a yearPrice +136.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

EHCEncompass HealthJNJJohnson & Johnson

Valuation

EHCJNJ
Valuation
Price$134.93$272.70
Market value$13.4B$657B
Enterprise value (EV)$15.9B$685B
P/E20.940.8
P/E, 5-year median19.221.9
P/B5.08.1
EV/EBIT14.938.6
Free cash flow yield3.4%3.1%

Results and growth

EHCJNJ
Results and growth
Revenue, 12 months$6.3B$99.3B
Net income, 12 months$644M$16.1B
Free cash flow, 12 months$457M$20.6B
Earnings per share, 12 months$6.40$6.59
Revenue growth, year on year10.5%6.1%
Revenue growth a year, past+10.7%over 5 years+2.7%over 5 years
EPS growth a year, past+14.2%over 5 years+14.9%over 5 years

Margins and returns on capital

EHCJNJ
Margins and returns on capital
Gross margin–67.6%
Operating margin––
Net margin10.2%16.2%
ROIC16.7%12.4%
ROE25.6%19.7%

Balance sheet

EHCJNJ
Balance sheet
Cash$100M$17.2B
Total debt$2.8B$44.7B
Net debt / EBITDA1.81.1
Interest cover8.4×18.0×

Dividends and buybacks

EHCJNJ
Dividends and buybacks
Dividend yield0.6%1.9%
Dividend per share, 12 months$0.78$5.28
Dividend growth a year, past-8.5%over 5 years+5.3%over 5 years
Buyback yield1.2%0.9%
Shareholder yield1.8%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: EHC or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Encompass Health or Johnson & Johnson?

By market value, Johnson & Johnson ($657B) is about 49.0 times Encompass Health ($13.4B), at today's prices.

How did EHC and JNJ stock do over the last 10 years?

Since November 18, 2016, EHC's price moved +314.0% and JNJ's +136.4%. With dividends: EHC +374.2% (+16.8% a year), JNJ +208.0% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, EHC or JNJ?

The dividend yield at today's price is 0.58% for Encompass Health and 1.94% for Johnson & Johnson. Over the last twelve months they paid $0.78 and $5.28 per share.

What is the P/E of EHC and JNJ?

At today's price, the P/E is 20.9 for EHC and 40.8 for JNJ. The median of the last five years was 19.2 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Encompass Health or Johnson & Johnson?

Over the last twelve months, the net margin was 10.2% for Encompass Health and 16.2% for Johnson & Johnson, and the operating margin – and –. Revenue was $6.3B and $99.3B.

Which is the better investment, Encompass Health or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.